Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1995-12-15
pubmed:abstractText
1. The effects of the benzopyran K-channel opener, BRL55834, on mechanical activity in bovine trachealis and rat portal vein were studied together with membrane currents in freshly-isolated single cells derived from these tissues. 2. BRL55834 (3 nM-1 microM) produced a concentration-dependent relaxation of bovine trachealis precontracted with 100 microM histamine and reduced the spontaneous mechanical activity of rat portal veins, effects which were antagonized by glibenclamide (1-10 microM) but were not reversible on washing. In contrast, charybdotoxin (250 nM) did not modify the spasmolytic effect of BRL55834 in bovine trachealis. 3. BRL55834 (10 nM-10 microM) did not relax segments of bovine trachealis precontracted with 80 mM KCl. 4. In some freshly-isolated single cells from bovine trachealis held at -10 mV, BRL55834 (3 microM) induced a time-independent outward K-current which was partially resistant to inhibition by glibenclamide (10 microM). In other cells, a very noisy, outwardly-rectifying and charybdotoxin-sensitive current developed in the presence of BRL55834 (3 microM) and in time-matched control cells. 5. In freshly-isolated single cells from rat portal vein held at -10 mV, BRL55834 (3 microM) induced a time- and calcium-independent outward K-current which was partially resistant (approximately 25% inhibition at +40 mV) to subsequent inhibition by glibenclamide (10 microM). In contrast, levcromakalim induced a time-independent outward K-current which was completely inhibited by glibenclamide 10 microM. 6. With the non-hydrolysable ATP analogue, AMP-PCP (5 mM), in the pipette, the ability of BRL55834 to induce a time-independent K-current in portal vein cells was markedly reduced (approximately 80% inhibition at +40 mV) whereas the effects of 10 microM levcromakalim were totally inhibited. 7. The glibenclamide-resistant current component induced by BRL55834 was totally inhibited by phentolamine (100 microM), a concentration that had no effect on the peak current (IBK(Ca)) induced by NS1619 (33 microM). 8. Stationary fluctuation analysis of the noise associated with the glibenclamide-insensitive K-current induced by BRL55834 in rat portal vein cells indicated that the unitary current flowing through the underlying channels was 0.26 pA at -10 mV, a value inconsistent with the involvement of BKCa. 9. It is concluded that the relaxations of both bovine trachea and rat portal vein produced by BRL55834 are associated with the opening of K-channels. These are probably identical to the ATP-sensitive K-channel opened by levcromakalim, although the involvement of an additional K-channel cannot be excluded. The reduced sensitivity of the BRL55834-induced changes to glibenclamide and toAMP-PCP may result from avid binding of BRL55834 to its site of action.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1467843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1482696, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1504756, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1601843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1664764, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-1666532, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-2417191, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-2452599, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-3231093, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-7506065, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-7534190, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-7881739, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-7932655, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8047164, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8058114, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8081072, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8137869, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8147710, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8220882, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8230110, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8298792, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8336339, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8401925, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8485637, http://linkedlifedata.com/resource/pubmed/commentcorrection/7582499-8494353
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1027-37
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Effects of BRL55834 in rat portal vein and bovine trachea: evidence for the induction of a glibenclamide-resistant, ATP-sensitive potassium current.
pubmed:affiliation
School of Biological Sciences, University of Manchester, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't